Latest updates for Crispr Debate

Fresh curated links around CRISPR debate are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Perspectives on Cathy Tie v. Glenn Cohen heritable human gene editing debate
  • Non-clinical safety assessment crucial for CRISPR-based gene therapies
  • CRISPR at 25: The Past, Present, and Future of Genome Editing

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

ipscell.com /2 weeks ago

Perspectives on Cathy Tie v. Glenn Cohen heritable human gene editing debate

I haven’t written that much about heritable human gene editing recently, but the topic and related technologies are still out there. We need to keep paying attention and having dia...

Read source
news-medical.net /1 month ago

Non-clinical safety assessment crucial for CRISPR-based gene therapies

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling precise correction, disruption, and regulation of disease-as...

Read source
genengnews.com /1 month ago

CRISPR at 25: The Past, Present, and Future of Genome Editing

In the first of a new series of GEN Keynote Webinars, Professor Rodolphe Barrangou, PhD (North Carolina State; EIC, The CRISPR Journal) offers a front-row perspective of the CRISPR...

Read source
reason.com /1 month ago

CRISPR Genome Editing and the Future of Down Syndrome Treatment

The ethics of using safe gene therapies to improve the health and cognition of Down syndrome children and adults.

Read source
labiotech.eu /1 month ago

How Epicrispr is leveraging CRISPR without cutting DNA

This week we dive into the Beyond Biotech archive to bring you a discussion with Dr Stanley Qi, the founder of Epicrispr. The post How Epicrispr is leveraging CRISPR without cutti...

Read source
jdsupra.com /1 month ago

The PTAB Reaffirms Priority Decision for CRISPR IP

On March 26, 2026, the U.S. Patent Office’s Patent Trial and Appeal Board (PTAB) reaffirmed its prior determination that the Broad Institute has priority over the University of Cal...

Read source
jdsupra.com /1 month ago

One Battle After Another: Broad Institute Wins at PTAB in CRISPR Dispute

Interference proceedings, though increasingly rare, are heavily evidence-based and determine which party is the first inventor when two or more applicants claim the same patentable...

Read source
bioengineer.org /3 weeks ago

SNU Professor Sangwoo Seo’s Team Develops Next-Generation CRISPR Biocontainment Technology to Control Microbial Survival...

In a groundbreaking advancement at the intersection of genome engineering and biocontainment, researchers at Seoul National University have developed a pioneering technology enabli...

Read source
genengnews.com /4 weeks ago

Gene Editing at Scale, Clinic Seeks Generalizable Therapies

What’s most exciting about CRISPR is its potential to shift medicine from managing disease to directly correcting its root cause. End-to-end pipelines and regulatory advances aim t...

Read source
phys.org /1 month ago

A built-in 'hairpin' mechanism in CRISPR-Cas13 prevents rogue RNAs

The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the emphasis has been on its underlying mechanisms and nuclea...

Read source
bioengineer.org /3 weeks ago

HKUST Researchers Pioneer World’s First DNA-Guided Gene Editing Tool, Revolutionizing Infectious Disease Diagnosis and A...

In a remarkable leap forward in gene editing technology, researchers at The Hong Kong University of Science and Technology (HKUST) have developed the world’s first DNA-guided CRISP...

Read source
lifespan.io /1 week ago

CRISPR-Based System Targets RNA and Kills Cells on Demand

Scientists have devised a CRISPR-based tool that can kill cells carrying a specific strand of RNA. The tested targets include cancerous and virus-infected cells [1]. Targeted assas...

Read source
nanowerk.com /1 month ago

A built-in 'hairpin' prevents rogue CRISPR RNAs

Bacteria independently evolved similar RNA hairpin structures to fix a wasteful flaw in different CRISPR immune systems, revealing convergent evolution at work.

Read source
labiotech.eu /1 month ago

Modified CRISPR tool targets Down syndrome mutation 

Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising preclinical results. The post Modified CRISPR tool targets Down s...

Read source
jdsupra.com /1 month ago

PTAB Again Rules in Favor of Broad in CRISPR-Cas9 Patent Dispute

The first patent interference between CVC and Broad concluded in 2018 after an appeal to the Federal Circuit appeals court. The Federal Circuit held that the parties’ claims did no...

Read source
fool.com /5 days ago

Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?

Are there significant gains ahead for one (or both) of these innovative biotechs?

Read source
bioengineer.org /4 weeks ago

Programmable RNA Targeting via DNA-Guided CRISPR-Cas12a

In a landmark advancement that could redefine molecular diagnostics, researchers have unveiled a groundbreaking DNA-guided CRISPR–Cas12a system capable of programmable RNA recognit...

Read source
genengnews.com /2 weeks ago

DNA‑Guided CRISPR Suggests a New Direction for RNA Editing

The platform, called ΨDNA, reprograms Cas12 nucleases to recognize and act on RNA using a DNA-based guide scaffold. In human cell lines, ΨDNA achieved 70–95% knockdown of endogenou...

Read source
nytimes.com /1 month ago

We Are on the Cusp of a Revolution in Rare Disease Treatment

We can’t let the most important medical achievement of a decade slip through our fingers.

Read source
nanowerk.com /3 weeks ago

New kind of CRISPR could treat viral infection and cancer by shredding sick cells' DNA

New CRISPR tool shreds targeted cells instead of editing genes, showing promise for killing diseased cells while sparing healthy ones.

Read source
bioengineer.org /2 weeks ago

CRISPR Technology Shows Promise in Inhibiting Hepatitis E Virus

In a groundbreaking development that could redefine antiviral therapy, researchers have engineered a CRISPR-Cas13d based system to combat hepatitis E virus (HEV) infection with rem...

Read source
genengnews.com /2 weeks ago

ASGCT 2026: AI-Optimized Cas12l Gene Editor Offers Compact Cas9 Alternative

The CEO of Caszyme, a biotech company in Vilnius, Lithuania, presented details of Cas12l, a novel compact Cas nuclease with a variety of potential research and therapeutic applicat...

Read source
inc.com /1 month ago

Milestone for Crispr: First-of-Its-Kind Gene Editing Treatment Successfully Passes Clinical Trial

A biotech company is looking to get approval next after their recent discovery.

Read source
genengnews.com /1 month ago

Expanding the Toolbox for Mammalian Genome Engineering

Despite significant advances in genome editing technologies over the past decade, integrating large DNA payloads into mammalian genomes efficiently, site-specifically, and safely h...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Crispr Debate

bioengineer.org

Recent coverage from public sources
Public source

feeds.feedburner.com

Recent coverage from public sources
Public source

ipscell.com

Recent coverage from public sources
Public source

phys.org

Recent coverage from public sources
Public source

reason.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source